Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest Bioavailability Stories

2014-04-18 23:08:24

OMICS Group announces the 5th World Congress on Bioavailabity and Bioequivalence: Pharmaceutical R&D Summit during Sep 29 - Oct 01, 2014 at Baltimore, USA with the theme “Innovative Approaches of BABE to Revolutionize the Next Generation Medicine” Los Angeles, CA (PRWEB) April 18, 2014 BABE-2014 is all set to explore the innovations, advancements in the field of pharmaceutical industry, which shows significant impact on the development of new and improved generic drugs. These...

2014-02-28 23:28:12

Updated patent expands protection of technology to enhance lunasin bioactivity and promote bioavailability. Chesterfield, MO (PRWEB) February 28, 2014 Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that the US Patent and Trademark Office has issued an expanded composition of matter patent for LunaRich® technology. LunaRich is a Reliv-exclusive nutritional ingredient. The updated patent further protects...

2014-02-19 16:24:33

February 2014 - Phase4 Pharmaceutical - AgeForce® Division introduces the first 100% bioavailable resveratrol supplement in a transdermal time-release patch. HALLANDALE BEACH, Fla., Feb. 19, 2014 /PRNewswire-iReach/ -- The Problem: Less than 1% of any orally ingested resveratrol supplement survives digestive stomach acid, intestinal bacteria, and first-pass liver functions, before entering the bloodstream. The Solution: According to the company's CEO Steve Lapidus: "We needed to bypass the...

2014-01-23 12:29:16

SAN DIEGO, Jan. 23, 2014 /PRNewswire/ -- Formex, LLC ("Formex"), a leader in pharmaceutical formulation and clinical trial manufacturing, announced today its sponsorship of the 3rd Drug Formulation & Bioavailability Conference to be held in Boston, MA from January 27-29, 2014. Formex CSO Blair West, Ph.D. will be joined by distinguished speakers from Merck & Co, F Hoffman-La Roche, Novartis and Boehringer-Ingelheim for a discussion entitled "Accelerating Time to Market...

2013-12-19 23:24:22

Aluronix Technologies Inc. has developed a new patented technology that enhances the health benefit of Hyaluronic Acid. Their soon to be released line of products will (1) allow the body to more efficiently absorb and metabolize Hyaluronan compounds, and (2) deliver them to where they are needed most. Montreal, QC (PRWEB) December 19, 2013 Aluronix Technologies Inc. has announced a new, patented method for significantly enhancing the effectiveness of Hyaluronic Acid health products. Using...

2013-12-17 08:28:17

FDA-funded Technology May Contribute to Improved Drug Safety by Predicting Drug Interactions Involving Transporters EXTON, Pa , Dec.17, 2013 /PRNewswire/ -- Absorption Systems, a world leader in drug transporters, announces the issuance of a Japanese patent protecting intellectual property around its CellPort Technologies(®) portfolio of in vitro test systems. The new patent, No. 5324456, extends the patent coverage on the company's transporter knockdown technology beyond patents...

2013-11-19 23:30:15

Avail is conducting a randomized, multi-center study of the pharmacodynamics, pharmacokinetics, and tolerability of a new liquid form drug in adult patients with chronic idiopathic constipation. DeLand, FL (PRWEB) November 19, 2013 *To see if you qualify for this Constipation Clinical Trial in Florida, visit Avail Clinical Research on the web (http://www.availclinical.com) or contact us directly at (386) 785-2404. There is no cost to participate, no insurance is required, and you may...

2013-11-19 23:26:07

ECOBOND® LBP successfully develops a lead poisoning prevention product to seal and treat lead paint hazards and reduce relative lead bioavailability to reduce the potential for childhood lead poisoning. Denver, CO (PRWEB) November 19, 2013 According to the US EPA, the leading cause of childhood lead poisoning is lead paint exposure. Although there is national focus on reducing lead paint hazards, especially for children; with up to 80% of all structures in the United States...

2013-11-14 08:33:09

WÄDENSWIL, Switzerland, November 14, 2013 /PRNewswire/ -- Frutarom Switzerland Ltd., Health BU, joins forces with Aquanova AG, the German pharma GMP manufacturer of superior ingredient formulas, to market NovaSOL(R) Curcumin, a solubilized, highly bioavailable form of curcumin for the dietary supplement and food manufacturing industries. (Photo: http://photos.prnewswire.com/prnh/20131114/653443 ) Frutarom Health will work in collaboration with Molecular...

2013-10-25 23:01:40

Integral BioSystems LLC now has exclusive rights to the name it coined for its ophthalmic platform pharmaceutical formulation development product, OcuSurf™, offering an innovative approach for those interested in developing ophthalmic medications with enhanced persistence and bioavailability for front-of-the-eye application. (PRWEB) October 25, 2013 Integral BioSystems LLC, led by 20+ year veteran of drug formulation development Shikha P. Barman, Ph.D., now offers clients formulation...